Research ArticleBasic Science Investigation
99mTc-Labeled Vasoactive Intestinal Peptide Receptor Agonist: Functional Studies
Venkat R. Pallela, Mathew L. Thakur, Sushanta Chakder and Satish Rattan
Journal of Nuclear Medicine February 1999, 40 (2) 352-359;
Venkat R. Pallela
Mathew L. Thakur
Sushanta Chakder


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
99mTc-Labeled Vasoactive Intestinal Peptide Receptor Agonist: Functional Studies
Venkat R. Pallela, Mathew L. Thakur, Sushanta Chakder, Satish Rattan
Journal of Nuclear Medicine Feb 1999, 40 (2) 352-359;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Evaluation of 99mTc-peptide-ZHER2:342 Affibody(R) molecule for in vivo molecular imaging
- VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study
- Imaging Spontaneous MMTVneu Transgenic Murine Mammary Tumors: Targeting Metabolic Activity Versus Genetic Products
- PET Imaging of VPAC1 Expression in Experimental and Spontaneous Prostate Cancer
- PET Imaging of CCND1 mRNA in Human MCF7 Estrogen Receptor Positive Breast Cancer Xenografts with Oncogene-Specific [64Cu]Chelator-Peptide Nucleic Acid-IGF1 Analog Radiohybridization Probes
- External Imaging of CCND1 Cancer Gene Activity in Experimental Human Breast Cancer Xenografts with 99mTc-Peptide-Peptide Nucleic Acid-Peptide Chimeras
- PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
- Y1-Mediated Effect of Neuropeptide Y in Cancer: Breast Carcinomas as Targets